Liver Transplantation with Tregs at MGH

(

LITTMUS_MGH

)

ITN Protocol #:

ITN073ST

Branded Name:

LITTMUS_MGH

ClinicalTrials.Gov ID:

NCT03577431

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Follow-up

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase I/II Drug Withdrawal Study of Alloantigen-Specific Tregs in Liver Transplantation

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

Rho Data Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

James Markmann, MD PhD James.Markmann@pennmedicine.upenn.edu

Work:

215-662-4083

Protocol Chair

Eva Guinan Eguinan@partners.org

Work:

617-632-4932

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-420-4250

Protocol Chair

Juliete Francisco Da Silva, PhD jsilva@immunetolerance.org

Work:

205-960-1065

Protocol Chair

Sindhu Chandran, MD schandran@immunetolerance.org

Work:

415-610-4284

Protocol Chair

Yvonne Morrison, MS yvonne.morrison@nih.gov

Work:

240-627-3577

Protocol Chair

Brian Goeckerman brian_goeckerman@rhoworld.com

Work:

(919) 595-6874

Protocol Chair

Theresa Scocca Theresa_Scocca@rhoworld.com

Work:

919-595-6312